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 Letter to the Editor:  
 
Test parameters for efficacy evaluations of aerial hydrogen peroxide decontamination systems 
 
Dear Editor, 
We comment on the difficulties posed when designing test criteria for the assessment of whole-
room aerial hydrogen peroxide decontamination systems. 
 
In-use efficacy data of biocides and decontamination systems provides essential information on 
performance in local hospital conditions, potential advantages and weaknesses that may not be 
obvious from manufacturer brochure material and commercial test data. Obtaining unbiased data 
on end-user efficacies is difficult and therefore an independent head-to-head study is useful. 
 
We have previously conducted a study to evaluate the reductions in environmental contamination 
during in-use operation of two commercially-available hydrogen peroxide whole-room disinfection 
systems [1].  
 
In the absence of defined, standardised national testing protocols we designed our own testing 
protocol for our setting. Our assessments involved in-house biological indicators (BIs) using a Gram-
positive, Gram-negative and a spore-bearing organism (MRSA, ESBL-producing Klebsiella 
pneumoniae and C. difficile 027 spores respectively) to simulate clinically-relevant organisms in the 
hospital environment and incorporated varying levels of soiling challenges to indicate best and 
worst-case efficacy outcomes when using either system 
 
Previous trials have employed 6-log Tyvek-pouched Geobacillus stearothermophilus BIs, commonly 
used for sterilisation-validation studies, to gauge potential reductions of contaminating organisms in 
the environment [2.3]. There are benefits to using such BIs; spore titres are pre-measured and the 
pouches pose little biological risk to the handler. Also, it is generally accepted that disinfection 
efficacy against “hardy” spores such as G. stearothermophilus and Bacillus atrophaeus may be 
interpreted as valid activity against lesser-tolerant spores and vegetative cells.  However these are 
not pathogens and the end-user (e.g. infection control practitioner) needs validation data against 
representative organisms of local concern, such as pathogenic organisms responsible for healthcare 
associated infections, rather than a surrogate organism.  
 
There are potential limitations to using BI pouches. Firstly, they do not incorporate a soil-challenge 
to simulate the attenuation of a biocide when exposed to dirt, debris and biological materials 
encountered in the environment. Secondly, due to penetrating limitations of hydrogen peroxide it is 
not clear whether BI pouches favour the penetration of smaller vapour particles used in vapour- 
hydrogen peroxide systems over aerosolised hydrogen peroxide. 
 
There are some considerations regarding target reductions of the contaminating organisms. 
Manufacturers may aim to demonstrate 5-6 log10 reductions in bacteria and spores through a single 
decontamination cycle, based on targets applied to hard-surface disinfectant solutions. It is not 
known how these criteria have been derived. Biocidal efficacy criteria for bacteria (EN1276) and 
spores (EN13704) aim to achieve 5log10 and 3log10 reductions within 5 and 60 minutes respectively. 
These bear little resemblance to the mode of delivery during aerial hydrogen peroxide disinfection: 
the volume of the hydrogen peroxide exposed to the surfaces is significantly less than required in 
the EN standards, while the time required to achieve the desired aerial concentration will differ 
between systems and room size. Therefore differences in total exposure duration to hydrogen 
peroxide will vary between manufacturers and affect final microbial reductions. 
  
 
Targets aiming for a high level disinfection of a bed area may be challenged with various limitations. 
Whole-room aerial disinfection systems are intended to eradicate any pathogenic organisms 
persisting after inadequate cleaning of surfaces or use of suboptimal preparations of disinfectant. 
Spores of C. difficile may remain viable on a surface even when an effective sporicide is used in 
disinfection [4]. The limited penetration-power of aerosolised and vapour hydrogen peroxide and 
the presence of organic dirt and debris may attenuate the activity of hydrogen peroxide. 
Additionally, characteristics of bactericidal activity in hydrogen peroxide decontamination systems 
may result in pronounced trailing-phases that allow low numbers of organisms to remain on surfaces 
unless the cycle duration is increased [5].Therefore terminal cleaning and enhanced 
decontamination (e.g. hydrogen peroxide disinfection) must be complementary and performed to a 
thorough standard to reduce microorganisms to numbers below transmissible levels. 
 
In an assessment identifying reservoirs of C. difficile spores in the clinical environment, levels in the 
most highly contaminated areas were approximately in the order of 3log10 numbers [6].  Thus, 
applying targets to achieve 5-6log reductions in bacteria and spores in efficacy-testing is arbitrary in 
practice.  
 
When evaluating hydrogen peroxide decontamination systems, organisms of local concern and 
relevant soiling challenges should be used to show in-use efficacy.  With increasing use of automated 
whole room disinfection devices a novel testing standard needs to be designed with clinically 
relevant reduction targets.  Comparison of devices between studies may be difficult for readers 
without a defined standard. 
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